Victoria Bray

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Ezra E.W. Cohen, Denis Soulières, Christophe Le Tourneau et al. · The Lancet · 2018 · 1.7K citations · Full text

Medicine, Oncology, Pharmacology +11

Evaluation of a Web-Based Cognitive Rehabilitation Program in Cancer Survivors Reporting Cognitive Symptoms After Chemotherapy

Victoria Bray, Haryana M. Dhillon, Melanie L. Bell et al. · Journal of Clinical Oncology · 2017 · 181 citations · Full text

Medicine, Oncology, Rehabilitation Medicine +17

Important differences and meaningful changes for the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog)

Melanie L. Bell, Haryana M. Dhillon, Victoria Bray et al. · Journal of Patient-Reported Outcomes · 2018 · 69 citations · Full text

Medicine, Oncology, Cancer Survivorship Care +16

Prognostic role of metabolic parameters of 18F-FDG PET-CT scan performed during radiation therapy in locally advanced head and neck squamous cell carcinoma

Myo Min, Peter Lin, Mark Lee et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 53 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Plasma next generation sequencing and droplet digital PCR‐based detection of epidermal growth factor receptor (EGFR) mutations in patients with advanced lung cancer treated with subsequent‐line osimertinib

Pei Ni Ding, Therese M. Becker, Victoria Bray et al. · Thoracic Cancer · 2019 · 53 citations · Full text

Medicine, Molecular Genetics, Oncology +17